{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidz6yq5vy4v5la3uplsiea3uc5bn4mnw6s4wgeqfrl5qzvhcyx7oi",
    "uri": "at://did:plc:xbuxpoeirs3ciraoxjua3jft/app.bsky.feed.post/3mflir7jmvq62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihpy37emky4pbx2jcaqttuknfuku5ozm3has23zwinnbrzdh3aftm"
    },
    "mimeType": "image/jpeg",
    "size": 946167
  },
  "path": "/2026/02/23/glp-1-study-retracted-ozempic-saxenda-contrave-statistics/",
  "publishedAt": "2026-02-23T19:28:22.000Z",
  "site": "https://retractionwatch.com",
  "tags": [
    "clinical study retractions",
    "int j obesity",
    "Continue reading Journal retracts GLP-1 study after researcher questions central finding"
  ],
  "textContent": "After reading a recent study about GLP-1 treatment in the International Journal of Obesity, David B. Allison immediately became skeptical about the paper’s analysis. The article, published in May 2024, found people who combined a GLP-1 therapy with another weight loss drug lost more weight than patients on GLP-1 therapy alone. “I could not really … Continue reading Journal retracts GLP-1 study after researcher questions central finding ",
  "title": "Journal retracts GLP-1 study after researcher questions central finding"
}